Literature DB >> 28192633

Ehlers-Danlos syndrome, classical type.

Jessica M Bowen, Glenda J Sobey, Nigel P Burrows, Marina Colombi, Mark E Lavallee, Fransiska Malfait, Clair A Francomano.   

Abstract

Classical EDS is a heritable disorder of connective tissue. Patients are affected with joint hypermobility, skin hyperextensibilty, and skin fragility leading to atrophic scarring and significant bruising. These clinical features suggest consideration of the diagnosis which then needs to be confirmed, preferably by genetic testing. The most recent criteria for the diagnosis of EDS were devised in Villefranche in 1997. [Beighton et al. (1998); Am J Med Genet 77:31-37]. The aims set out in the Villefranche Criteria were: to enable diagnostic uniformity for clinical and research purposes, to understand the natural history of each subtype of EDS, to inform management and genetic counselling, and to identify potential areas of research. The authors recognized that the criteria would need updating, but viewed the Villefranche nosology as a good starting point. Since 1997, there have been major advances in the molecular understanding of classical EDS. Previous question marks over genetic heterogeneity have been largely surpassed by evidence that abnormalities in type V collagen are the cause. Advances in molecular testing have made it possible to identify the causative mutation in the majority of patients. This has aided the further clarification of this diagnosis. The aim of this literature review is to summarize the current knowledge and highlight areas for future research.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; cEDS; classical type; joint hypermobility; skin fragility; skin hyperextensibility

Mesh:

Substances:

Year:  2017        PMID: 28192633     DOI: 10.1002/ajmg.c.31548

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  34 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

2.  Clinical variability in children with dolichoarteriopathies of the internal carotid artery.

Authors:  Thomas Foiadelli; Rosario Ippolito; Riccardo Corbetta; Anna Maria Simoncelli; Rossella Amariti; Amelia Licari; Gianluigi Marseglia; Salvatore Savasta
Journal:  Childs Nerv Syst       Date:  2019-11-07       Impact factor: 1.475

3.  Use of Cluster Analysis to Delineate Symptom Profiles in an Ehlers-Danlos Syndrome Patient Population.

Authors:  Jane R Schubart; Eric Schaefer; Alan J Hakim; Clair A Francomano; Rebecca Bascom
Journal:  J Pain Symptom Manage       Date:  2019-05-31       Impact factor: 3.612

Review 4.  Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

Authors:  Josephina A N Meester; Aline Verstraeten; Dorien Schepers; Maaike Alaerts; Lut Van Laer; Bart L Loeys
Journal:  Ann Cardiothorac Surg       Date:  2017-11

Review 5.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

Review 6.  Biomaterials to Mimic and Heal Connective Tissues.

Authors:  Benjamin R Freedman; David J Mooney
Journal:  Adv Mater       Date:  2019-03-25       Impact factor: 30.849

7.  Compendium of causative genes and their encoded proteins for common monogenic disorders.

Authors:  Tucker L Apgar; Charles R Sanders
Journal:  Protein Sci       Date:  2021-09-21       Impact factor: 6.993

8.  Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome.

Authors:  Keren Machol; Urszula Polak; Monika Weisz-Hubshman; I-Wen Song; Shan Chen; Ming-Ming Jiang; Yuqing Chen-Evenson; Mary Ann E Weis; Douglas R Keene; David R Eyre; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

Review 9.  ZIP13: A Study of Drosophila Offers an Alternative Explanation for the Corresponding Human Disease.

Authors:  Guiran Xiao; Bing Zhou
Journal:  Front Genet       Date:  2018-01-31       Impact factor: 4.599

Review 10.  Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts.

Authors:  Nicoletta Zoppi; Nicola Chiarelli; Marco Ritelli; Marina Colombi
Journal:  Int J Mol Sci       Date:  2018-03-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.